"Kaletra" tj. Lopinavir–Ritonavir NEEFEKTIVNA u lijecenju!!! "CONCLUSIONS In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit." https://www.nejm.org/doi/full/10.1056/NEJMoa2001282
@Orwell BACATE PARE i nepotrebno eksperimentisete nad pacijentima, iako su drugi vec utvrdili koji su bez efekta od tih antiviralnih lijekova! Farmaceutska industrija TRLJA RUKE!
Prikaži sve komentare (74)